AZTA
Azenta, Inc. · Healthcare · Medical Instruments & Supplies
Last
$34.08
−$2.44 (−6.68%) 4:00 PM ET
Prev close $36.52
Open $36.60
Day high $37.38
Day low $33.02
Volume 1,256,084
Avg vol 1,120,475
Mkt cap
$1.60B
EV/Sales
2.30
P/E ratio
-12.13
FY Revenue
$613.57M
EPS
-2.81
Gross Margin
43.36%
Div yield
0.00%
Sector
Healthcare
AI report sections
AZTA
Azenta, Inc.
No AI report section text found yet for this symbol.
AI summarized at 10:11 AM ET, 2026-10-02
AI summary scores
INTRADAY: 72 SWING: 81 LONG: 39
Volume vs average
Intraday (cumulative)
+79% (Above avg)
Vol/Avg: 1.79×
RSI
53.45 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.02 (Weak)
MACD: 0.02 Signal: 0.04
Short-Term
-0.08 (Weak)
MACD: 1.20 Signal: 1.29
Long-Term
+0.09 (Strong)
MACD: 2.01 Signal: 1.92
Intraday trend score 37.02

Latest news

AZTA 12 articles Positive: 0 Neutral: 0 Negative: 12
Negative GlobeNewswire Inc. • Rosen Law Firm
FRVO Investor News: If You Have Suffered Losses in Fervo Energy Company, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm has announced investigations into potential securities claims against multiple companies including Fervo Energy Company (NASDAQ: FRVO), Triller Group Inc., and Azenta, Inc., alleging that these companies may have issued materially misleading business information to investors. The firm is preparing class action lawsuits seeking recovery of investor losses through contingency fee arrangements.

FRVO ILLR AZTA securities fraud class action lawsuit investor losses misleading information shareholder rights
Sentiment note

Company is under ongoing investigation for potential securities claims on behalf of shareholders, suggesting alleged misconduct or misleading disclosures.

Negative GlobeNewswire Inc. • Rosen Law Firm
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following the resignation of President and CEO John P. Marotta on August 22, 2026. The announcement triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses related to allegations of materially misleading business information.

AZTA securities fraud class action lawsuit CEO resignation investor losses Form 8-K filing stock decline
Sentiment note

The company faces a securities investigation due to allegations of materially misleading business information. The unexpected resignation of the CEO and President resulted in a significant 12% stock price decline, indicating loss of investor confidence and potential legal liability.

Negative GlobeNewswire Inc. • Rosen Law Firm
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following allegations of materially misleading business information. The investigation was prompted by CEO John P. Marotta's resignation on August 22, 2026, which triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses.

AZTA securities fraud class action lawsuit CEO resignation investor losses misleading disclosures stock decline
Sentiment note

The company is under investigation for issuing materially misleading business information to investors. The sudden resignation of the CEO and President resulted in a significant 12% stock price decline, indicating loss of investor confidence and potential underlying corporate governance issues.

Negative GlobeNewswire Inc. • Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

Pomerantz LLP is investigating potential securities fraud at Azenta, Inc. following the resignation of CEO John Marotta on August 24, 2026. The announcement triggered a significant stock price decline of 12.09% ($4.52 per share), closing at $32.88. Investors are being invited to join a class action lawsuit.

AZTA securities fraud CEO resignation class action lawsuit stock price decline corporate misconduct
Sentiment note

CEO resignation combined with a 12.09% stock price drop and ongoing securities fraud investigation indicates significant negative developments for the company and its investors.

Negative Benzinga • Glancy Prongay Wolke & Rotter Llp
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Azenta, Inc. (AZTA) faces an ongoing securities fraud investigation following disappointing Q2 2026 earnings results on May 5, 2026. The company missed consensus estimates, reported a $149 million goodwill impairment, and significantly reduced its 2026 guidance, causing the stock to plummet 25.3% to $18.38 per share. A securities law firm is investigating potential federal securities law violations and urging affected shareholders to contact them.

AZTA securities fraud Azenta earnings miss goodwill impairment guidance reduction shareholder lawsuit stock decline
Sentiment note

Company missed Q2 2026 earnings estimates, reported significant goodwill impairment of $149 million, substantially reduced full-year 2026 guidance, and faces securities fraud investigation. Stock price fell 25.3% following the announcement, indicating severe loss of investor confidence.

Negative GlobeNewswire Inc. • Levi & Korsinsky, Llp
Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)

Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026, but disclosed a $149 million goodwill impairment tied to its Multiomics segment in May 2026, alongside a $160.8 million net loss and substantial guidance reduction. The company did not reference the impairment risk during its February reaffirmation, prompting an investigation into potential securities law violations.

AZTA goodwill impairment guidance reduction misleading statements securities violation Multiomics segment net loss shareholder losses
Sentiment note

Company disclosed a $149 million goodwill impairment and $160.8 million net loss while significantly reducing full-year guidance, just three months after reaffirming positive outlook. The failure to disclose impairment risks during February guidance reaffirmation raises concerns about transparency and potential securities violations, resulting in significant shareholder losses.

Negative GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. (NASDAQ:AZTA) on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm

Law firm Bragar Eagel & Squire is investigating Azenta, Inc. following the company's May 5, 2026 announcement of disappointing Q2 fiscal 2026 results, execution gaps, and a $149 million goodwill impairment charge. Azenta significantly lowered its full-year guidance and extended its long-range plan targets, causing its stock to plummet 25% from $24.61 to $18.38 per share.

AZTA securities investigation goodwill impairment missed guidance stock decline execution gaps shareholder lawsuit
Sentiment note

Company disclosed significant operational underperformance with execution gaps, a substantial $149 million goodwill impairment charge, substantial downward revision of full-year guidance (from 3-5% growth to -2% to 1%), and extended timeline for achieving long-range targets. Stock price fell 25% following the announcement, and the company is now subject to a securities investigation.

Negative GlobeNewswire Inc. • Kirby Mcinerney Llp
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Azenta, Inc. reported disappointing Q2 fiscal 2026 results with execution gaps and weak demand, recording a $149 million goodwill impairment charge. The company significantly reduced its full-year guidance and extended long-range plan targets, causing its stock to plunge 25% on May 6, 2026. Law firm Kirby McInerney LLP is investigating potential securities law violations by the company and its senior management.

AZTA securities violation goodwill impairment guidance reduction stock decline shareholder investigation execution gaps demand weakness
Sentiment note

Company reported disappointing Q2 results with execution gaps, weak demand environment, $149 million goodwill impairment charge, significant guidance reduction (from 3-5% growth to -2% to +1%), and stock price declined 25% following the announcement. Additionally, securities law violations are being investigated.

Negative GlobeNewswire Inc. • Schall Law Firm
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm announced an investigation into Azenta, Inc. for potential securities law violations following the company's May 5, 2026 earnings announcement. Azenta missed analyst estimates on revenue and EPS due to execution shortfalls and weak demand, leading to a 25.3% stock price decline and a reduced full-year 2026 outlook.

AZTA securities litigation shareholder rights earnings miss stock decline financial guidance reduction investor losses
Sentiment note

The company missed analyst estimates on revenue and EPS, cited execution-related shortfalls and weak demand environment, reduced full-year guidance, and experienced a significant 25.3% stock price decline. Additionally, the company is under investigation for potential securities law violations.

Negative GlobeNewswire Inc. • Levi & Korsinsky, Llp
AZTA SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Azenta, Inc. for Possible Securities Law Violations

Azenta, Inc. (NASDAQ: AZTA) recorded a $149 million goodwill impairment and slashed FY 2026 guidance on May 5, 2026, just weeks after reaffirming confidence in its growth trajectory on the Q1 earnings call. The impairment was tied to the Multiomics segment. Levi & Korsinsky is investigating whether the company made materially misleading statements to investors regarding risks to the Multiomics segment and factors underlying the goodwill impairment.

AZTA goodwill impairment guidance cut securities fraud investigation Multiomics segment shareholder losses materially misleading statements
Sentiment note

Company recorded a $149 million goodwill impairment, posted a $160.8 million net loss, and cut full-year revenue and margin guidance just weeks after reaffirming confidence in its outlook. This represents a significant deterioration in financial performance and investor confidence, with ongoing securities fraud investigation into potentially misleading statements.

Negative GlobeNewswire Inc. • Kirby Mcinerney Llp
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Azenta, Inc. reported disappointing Q2 fiscal 2026 results with execution gaps and weak demand, recording a $149 million goodwill impairment charge. The company significantly reduced its full-year guidance and extended long-range plan targets, causing its stock to plunge 25% from $24.61 to $18.38. Law firm Kirby McInerney LLP is investigating potential securities law violations by the company and its senior management.

AZTA securities violation goodwill impairment guidance reduction stock decline shareholder investigation financial results miss demand weakness
Sentiment note

Company reported disappointing Q2 results with execution gaps, weak demand environment, $149 million goodwill impairment charge, significant reduction in full-year revenue guidance (from 3-5% growth to -2% to +1%), reduced EBITDA margin outlook, and extended timeline for long-range targets. Stock price declined 25% on the announcement, and securities law violations are being investigated.

Negative Benzinga • Glancy Prongay Wolke & Rotter Llp
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

A securities fraud investigation has been announced against Azenta, Inc. after the company missed Q2 2026 earnings estimates, reported a $149 million goodwill impairment, and significantly reduced its 2026 guidance. The stock fell 25.3% to $18.38 on May 6, 2026, prompting a law firm to seek investors who suffered losses.

AZTA securities fraud Azenta earnings miss goodwill impairment guidance reduction stock decline shareholder lawsuit
Sentiment note

Company missed consensus earnings estimates, reported significant goodwill impairment of $149 million, substantially reduced 2026 revenue guidance from 3-5% growth to -2% to +1%, reduced EBITDA margin outlook, and extended long-range plan targets by one year. Stock price declined 25.3% following the announcement, and a securities fraud investigation has been initiated.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal